Ir a las Transacciones
Salud

Prestige Inhome Care has found a long-term strategic partner

Prestige Inhome Care has received a growth capital investment from Yorkway Private. The newly formed partnership will provide growth capital for geographic expansion, increasing Prestige’s range of services and potential future acquisitions. The investment in Prestige is in line with Yorkway’s mandate to invest in leading Australian mid-market companies with strong management teams, backed by significant growth tail winds, as is the case in the aged care industry.

Established in 2005, Prestige Inhome Care is the leading in-home aged and NDIS care provider in Australia with over 1,800 clients, serviced by a team of more than 1,000 registered nurses and professional carers. Prestige provides first-class, premium care to its clientele across Victoria, NSW and Queensland, allowing them to stay in the comfort of their own home.

Oaklins’ team in Australia acted as corporate advisor to the shareholders of Prestige, who were seeking an investment partner to provide growth capital. The team worked closely alongside Prestige through a comprehensive investor roadshow process to find the right-fit investor to support Prestige’s future growth. The transaction adds to Oaklins’ track record advising founder-owned businesses on sourcing institutional growth capital and support that will help catapult the business to another level of success.

Contáctese con el equipo de la transacción

Scott McInnes

Director Ejecutivo
Melbourne, Australia
Oaklins Henslow

Ryan Whitelegg

Director Ejecutivo
Melbourne, Australia
Oaklins Henslow

Valentin Couleau

Asociado Director
Melbourne, Australia
Oaklins Henslow

Hannah Danks

Analista
Melbourne, Australia
Oaklins Henslow

George Fry

Analista
Melbourne, Australia
Oaklins Henslow

Transacciones relacionadas

FRP Advisory Group plc has finalized a successful secondary placing
Servicios Financieros

FRP Advisory Group plc has finalized a successful secondary placing

FRP Advisory Group plc has completed a fundraising. The book was oversubscribed and approximately £20.4 million (US$33 million) of shares were sold by certain directors and partners of FRP to new and existing institutional investors at 128 pence per ordinary share.

Aprenda más
Leika Medical Equipments Ltd. has been acquired by Angus Capital
Private Equity | Salud

Leika Medical Equipments Ltd. has been acquired by Angus Capital

The shareholders of Leika Medical Equipments Ltd. have sold the company to Angus Capital.

Aprenda más
Phen’X Technologies has sold a majority stake to Ciclad
Private Equity | Salud | Maquinaria y Componentes Industriales

Phen’X Technologies has sold a majority stake to Ciclad

The shareholders of Phen’X Technologies have completed a primary majority LBO with private equity fund Ciclad.

Aprenda más